Sandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in February

Sandoz Group AG (OTCMKTS:SDZNY) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 366,500 shares, a decline of 52.6% from the January 31st total of 773,500 shares. Based on an average trading volume of 95,900 shares, the short-interest ratio is currently 3.8 days.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. UBS Group cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 3rd. BNP Paribas cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.

Sandoz Group Stock Performance

Shares of OTCMKTS:SDZNY traded down $0.30 during midday trading on Friday, hitting $43.80. 25,962 shares of the company’s stock traded hands, compared to its average volume of 39,512. The firm’s fifty day moving average price is $45.06 and its two-hundred day moving average price is $43.93. Sandoz Group has a twelve month low of $27.79 and a twelve month high of $49.81.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.